Influenza genetic sequence patents: where intellectual property clashes with public health needs

Author： Andrews Lori B Shackelton Laura A

ISSN： 1746-0794

Source： Future Virology, Vol.3, Iss.3, 2008-05, pp. : 235-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The complexities of intellectual property law are to be made clearer to health researchers

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 351, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

The role of intellectual property in biotechnology

By Thomas S.M.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 9, 1997-09 ,pp. : 929-936

Informa Healthcare

Access to resources Recommend Favorite

Nature's Medicines: Traditional Knowledge and Intellectual Property Management. Case Studies from the National Institutes of Health (NIH), USA

Current Drug Discovery Technologies, Vol. 2, Iss. 4, 2005-12 ,pp. : 203-219

Bentham Science Publishers

Access to resources Recommend Favorite

Merck: the scattering of DNA sequence patents

By Thomas S.M. Brady M. Burke J.F.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 12, 1998-12 ,pp. : 1393-1400

Informa Healthcare

Access to resources Recommend Favorite

Merck: the scattering of DNA sequence patents

By Thomas S.M. Brady M. Burke J.F.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 12, 1997-12 ,pp. : 1393-1400

Informa Healthcare

Access to resources Recommend Favorite